New hope for elderly lymphoma patients: targeted pill without chemo

NCT ID NCT07207785

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This study tests a daily pill called pirtobrutinib in elderly patients (70+) with mantle cell lymphoma who are too frail for standard chemotherapy. The drug targets a specific protein to control the cancer. Patients will take the pill until the disease worsens or side effects become unacceptable. The goal is to see how long the cancer stays under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia

    Palermo, Italy

    Contact Email: •••••@•••••

    Contact

  • A.O. S. Maria di Terni - S.C. Oncoematologia

    Terni, Italy

    Contact Email: •••••@•••••

    Contact

  • AOU Integrata di Verona - U.O. Ematologia

    Verona, Italy

    Contact Email: •••••@•••••

    Contact

  • AOU Ospedali Riuniti - Clinica di Ematologia

    Ancona, Italy

    Contact Email: •••••@•••••

    Contact

  • AOU Senese - U.O.C. Ematologia

    Siena, Italy

    Contact Email: •••••@•••••

    Contact

  • ASST Spedali Civili di Brescia - Ematologia

    Brescia, Italy

    Contact Email: •••••@•••••

    Contact

  • Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico

    Avellino, Italy

    Contact Email: •••••@•••••

    Contact

  • Azienda Ospedaliera Universitaria Policlinico - S. Marco - UOC di Ematologia

    Catania, Italy

    Contact Email: •••••@•••••

    Contact

  • Azienda USL Piacenza - UOC Ematologia e Centro Trapianti

    Piacenza, Italy

    Contact Email: •••••@•••••

    Contact

  • Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia

    Reggio Emilia, Italy

    Contact Email: •••••@•••••

    Contact

  • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia

    Milan, Italy

    Contact Email: •••••@•••••

    Contact

  • IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia

    Meldola, Forlì-Cesena, Italy

    Contact Email: •••••@•••••

    Contact

  • Istituto Clinico Humanitas - U.O. Ematologia

    Rozzano, Milano, Italy

    Contact Email: •••••@•••••

    Contact

  • Nuovo Ospedale degli Infermi - SSD Ematologia

    Biella, Italy

    Contact Email: •••••@•••••

    Contact

  • Ospedale Ca Foncello - S.C di Ematologia

    Treviso, Italy

    Contact Email: •••••@•••••

    Contact

  • Ospedale di Circolo - U.O.C Ematologia

    Varese, Italy

    Contact

    Contact

  • P.O. Spirito Santo di Pescara - UOC Ematologia Dipartimento Oncologico Ematologico - ASL Pescara

    Pescara, Italy

    Contact Email: •••••@•••••

    Contact

  • Parma - AOU di Parma - UOC Ematologia e CTMO

    Parma, Italy

    Contact Email: •••••@•••••

    Contact

  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia "Seragnoli"

    Bologna, Italy

    Contact Email: •••••@•••••

    Contact

  • Vicenza - ULSS 8 Berica - Ospedale S. Bortolo - Ematologia

    Vicenza, Italy

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.